Seelos Therapeutics (SEEL)
OTHER OTC:SEEL
Holding SEEL?
Track your performance easily

Seelos Therapeutics (SEEL) Cash flow

1,218 Followers

Seelos Therapeutics Cash Flow

SEEL's free cash flow for Q2 2024 was $-972.00K. For the 2024 fiscal year, SEEL's free cash flow was decreased by $37.69M and operating cash flow was $-972.00K. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Operating Cash Flow
$ -17.27M$ -23.91M$ -61.60M$ -48.99M$ -20.91M$ -19.30M
Investing Cash Flow
---$ 5.64M$ 192.00K$ 3.00M
Financing Cash Flow
$ 3.09M$ 11.38M$ -1.60M$ 112.07M$ 26.31M$ 29.52M
Cash Flow From Discontinued Operation
------
Other Cash Adjustment Inside Changein Cash
------
End Cash Position
$ 9.24M$ 3.00M$ 15.53M$ 78.73M$ 15.66M$ 10.26M
Income Tax Paid Supplemental Data
------
Interest Paid Supplemental Data
$ 382.00K$ 505.00K$ 11.00K$ 10.00K$ 11.00K$ 16.00K
Issuance Of Capital Stock
$ 40.00K$ 165.00K$ 556.00K$ 98.06M$ 15.21M$ 25.01M
Issuance Of Debt
$ -5.70M$ -7.64M$ -1.89M$ -13.55M$ 11.05M-
Repayment Of Debt
$ -5.70M$ -7.64M$ -1.89M$ -13.55M--
Free Cash Flow
$ -17.27M$ -23.91M$ -61.60M$ -48.99M$ -20.91M$ -19.30M
Domestic Sales
------
Foreign Sales
------
Currency in USD

Seelos Therapeutics Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis